Benjamin Linas is an Infectious Disease physician affiliated with Boston Medical Center. OpenAlex indexes 264 publications with 6,533 citations (h-index 39); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
801 Massachusetts Ave Ste 2
Boston, MA 021182605
Telephone
617-414-7019Provider last certified this registry record 21 Jun 2023.
Clinical trials
- MA-CEAL Community Health Ambassador Program
Sponsor: Boston Medical Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2021)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
100%Statin57.1%Atorvastatin Calcium100%Part D<11 patientsACE inhibitor42.9%Lisinopril100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
5 NIH research awards on record, funded 2007–2026 per NIH RePORTER. The latest:
- Researching Effective Strategies to Prevent Opioid Death (RESPOND)
Boston Medical Center
FY2026$797,674R01DA046527 - Substance Use Modeling Consortium Workshop to Support the Public Health Response to the Overdose Crisis in North America
Boston Medical Center
FY2026$24,512R13DA052198 - Researching Effective Strategies to Prevent Opioid Death (RESPOND)
Boston Medical Center
FY2025$793,161R01DA046527
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Evaluation of individual and ensemble probabilistic forecasts of COVID-19 mortality in the United States
Proceedings of the National Academy of Sciences
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Alice Jacobs, MD
Boston Medical Center
Carlos Kase, MD
Boston Medical Center
Sushrut Waikar, MD
Boston Medical Center
Geoffrey Oxnard, MD
Boston Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”